GENEVA – The global health community has converged at the World Health Assembly (WHA), marking a pivotal moment in international health policy. Over the course of the latest sessions, delegates from across the globe have laid the groundwork for a new era of disease control, strategic foresight, and information integrity. From charting a post-2030 path to eliminate tuberculosis to addressing the silent epidemic of liver disease and the systemic neglect of bleeding disorders, the Assembly has signaled a robust commitment to addressing both age-old health burdens and the modern challenges of the digital age.
I. Charting the Future: A Post-2030 Strategy for Tuberculosis
The Assembly has formally endorsed a landmark decision requesting the Director-General to spearhead the development of a comprehensive post-2030 tuberculosis (TB) strategy. This initiative, which will be finalized for submission to the Eighty-first World Health Assembly in 2028, is designed to serve as the North Star for the next generation of global TB control.
The Evolution of TB Response
The current End TB Strategy has achieved remarkable success. Between 2000 and 2024, expanded treatment protocols saved an estimated 83 million lives. Furthermore, 2024 served as a watershed year, marking the first sustained post-pandemic decline in TB incidence and the highest level of access to essential services ever recorded.
However, the path to eradication remains obstructed. Despite these gains, tuberculosis continues to claim lives at an alarming rate, remaining one of the world’s leading infectious killers. The Assembly acknowledged that global targets under the 2030 Agenda for Sustainable Development are currently off-track. This stagnation is attributed to a "perfect storm" of challenges: chronic underfunding, the lingering aftershocks of pandemic-related service disruptions, rising inequality, and the destabilizing effects of conflict and climate-related displacement.
The new post-2030 strategy will be meticulously aligned with primary health care (PHC) systems and universal health coverage (UHC) agendas. By integrating TB care into broader global health security frameworks, the WHO aims to ensure that the response is resilient enough to withstand future crises.
II. Addressing the Rising Burden of Steatotic Liver Disease (SLD)
In a significant policy shift, the Assembly has officially recognized steatotic liver disease (SLD)—formerly known as fatty liver disease—as a major, burgeoning contributor to the global noncommunicable disease (NCD) crisis.
A Hidden Epidemic
Affecting an estimated 1.7 billion people worldwide, SLD is rapidly becoming one of the most common causes of chronic liver dysfunction. The condition is intrinsically linked to the global rise in obesity, type 2 diabetes, and cardiovascular disease. While metabolic factors drive the majority of cases, alcohol-associated liver disease remains a critical component of the overall burden.
If left unmanaged, SLD can progress from simple fatty accumulation to liver fibrosis, cirrhosis, and, eventually, hepatocellular carcinoma. This progression places an unsustainable strain on healthcare systems, which are already struggling to manage the escalating costs of NCDs.
The Mandate for Action
The resolution passed by the Assembly mandates several key actions for Member States:
- Strategic Integration: Countries are urged to fold SLD prevention and management into existing national NCD strategies.
- Multisectoral Intervention: Addressing the root causes—such as unhealthy diets, physical inactivity, and harmful alcohol consumption—requires a "Health in All Policies" approach.
- Enhanced Screening: There is a specific call to strengthen diagnostic capacities, particularly for vulnerable populations, including children and adolescents, who are increasingly presenting with metabolic complications.
- Technical Support: The WHO is tasked with providing biennial progress reports and technical assistance to countries as they refine their national surveillance and care frameworks.
III. Equity and Advocacy: Supporting Those with Bleeding Disorders
For too long, individuals living with haemophilia and other bleeding disorders have occupied a "blind spot" in global health policy. The Assembly’s adoption of a new resolution aims to close this long-standing equity gap.
The Reality of Living with Bleeding Disorders
Haemophilia and related conditions, such as von Willebrand Disease, impair the body’s ability to clot blood. Without timely diagnosis and regular prophylaxis, patients face the constant threat of spontaneous internal bleeding, joint damage, chronic disability, and significantly reduced quality of life. Current data suggests that nearly 70% of those living with haemophilia globally remain undiagnosed, effectively leaving them without the life-saving care they require.
A Concrete Commitment to Care
The new resolution represents a comprehensive framework to dismantle the barriers facing these patients:
- Essential Medicines: Member States are encouraged to prioritize the inclusion of factor concentrates and novel non-factor therapies in their National Essential Medicines Lists.
- Policy Integration: By integrating bleeding disorder management into broader NCD, maternal health, and primary care policies, countries can ensure that specialized care is not siloed.
- Data and Awareness: Strengthening national data collection is essential for resource allocation, while public awareness campaigns are being prioritized to reduce the stigma that often prevents families from seeking a diagnosis.
IV. Rebuilding Trust: Confronting Health Mis- and Disinformation
Perhaps the most contemporary challenge discussed at the Assembly was the proliferation of health-related misinformation. In a high-level Strategic Roundtable, leaders from government, media, civil society, and the scientific community united to categorize the current information crisis as a direct threat to public health.
Moving Beyond "Communication Challenges"
Participants reached a sobering consensus: mis- and disinformation are not merely peripheral communication hurdles; they are active impediments to the delivery of medical interventions. When public trust in science erodes, vaccine uptake drops, adherence to treatment regimens falters, and public health directives are ignored.
The roundtable highlighted that the solution cannot be purely technological. While tech platforms play a role, the strategy must be "whole-of-government" and community-centered. Key strategies discussed included:
- Empowering Frontline Responders: Health workers remain the most trusted messengers. Providing them with the tools and training to address myths in clinical settings is a priority.
- Proactive Information Ecosystems: Rather than just correcting misinformation after it spreads, the goal is to build resilient ecosystems where high-quality, evidence-based information is accessible and understandable.
- Scientific Credibility: Strengthening the networks that disseminate evidence is crucial to ensuring that the WHO and national health authorities remain the primary sources of truth during health emergencies.
V. Implications and Future Outlook
The sessions of the World Health Assembly reflect a sophisticated, multifaceted approach to 21st-century health. By linking the eradication of an ancient scourge like tuberculosis with the management of modern metabolic diseases and rare bleeding disorders, the Assembly is reinforcing the concept of "Health for All."
The emphasis on data, integration, and trust serves as the common thread connecting these diverse agenda items. Whether through the development of the post-2030 TB strategy or the fight against digital falsehoods, the message from Geneva is clear: health systems must become more proactive, inclusive, and evidence-driven.
As the world looks toward the 2028 UN High-Level Meeting on TB, the momentum generated at this Assembly will be vital. The path forward requires not just political declarations, but sustained financial investment and a genuine commitment to addressing the social determinants of health—ranging from climate displacement to the quality of the information that shapes human behavior. The decisions made here have laid the foundation; the work of implementation, however, now shifts to the national level, where the true measure of success will be found in the lives saved and the health outcomes improved.
About the Author
